Ubc9 is an E2-conjugating enzyme that transfers the activated small ubiquitin-like modifier (SUMO) to protein substrates, and thus it has an important function in sumoylation-mediated cellular pathways. We have earlier reported that Ubc9 promotes tumor growth in the xenograft mouse model using breast cancer cell line MCF-7 in part through regulation of Bcl-2 expression. In this study, we show that ectopic expression of wild-type Ubc9 (Ubc9-WT) promotes cell invasion and metastasis. Surprisingly, the dominant negative mutant Ubc9 (Ubc9-DN) also causes the same phenotype, indicating that the ability of Ubc9 to promote invasion and metastasis is distinct from its ability to conjugate SUMO to protein substrates. Of considerable interest, several microRNAs such as miR-224 are regulated by Ubc9. Although ectopic expression of Ubc9 causes downregulation of miR-224, suppression of Ubc9 by Ubc9-siRNAs leads to its upregulation. We further show that miR-224 can inhibit cell invasion and directly targets CDC42 and CXCR4, and that suppression of CDC42 and CXCR4 by RNAi causes inhibition of Ubc9-mediated invasion. Together, these results show a molecular link between Ubc9 and the metastasis genes such as CDC42 and CXCR4, and thus provide new insight into the mechanism by which Ubc9 promotes tumor invasion and metastasis.
Introduction
Protein modification involving small ubiquitin-like modifier (SUMO) has been shown to have an important function in regulation of diverse cellular functions (Melchior, 2000; Johnson, 2004) . Sumoylation is a multi-step process and requires several enzymes. Among them is the E2-conjugating enzyme Ubc9, which transfers the activated SUMO to protein substrates (Johnson, 2004) . As most of SUMO substrates are nuclear proteins including many transcription factors or co-factors, SUMO/Ubc9 impact a variety of cellular pathways such as cell growth, proliferation, apoptosis and even chromatin remodeling (Baek, 2006) .
Although it is well known that Ubc9 impacts cellular pathways through sumoylation, Ubc9 can also regulate cellular pathways independent of sumoylation. In this scenario, Ubc9 may function as a regulator of nuclear transport or protein activity or as a co-regulator of transcription. For example, both wild type and sumoylation-defective mutant (or dominant negative) Ubc9 regulate the nuclear localization of Vsx-1, a proteinregulating bipolar cell differentiation during zebrafish retinogenesis, by binding to a nuclear localization signal at the N-terminus of the Vsx-1 homeodomain (Kurtzman and Schechter, 2001) . Emerging evidence further suggests that Ubc9 can also function as a transcription co-factor independent of sumoylation in mammalian cells. For example, Ubc9 has been shown to modulate transcriptional activity of glucocorticoid receptors by directly binding to this protein (Kaul et al., 2002) . Similarly, like the wild-type counterparts, the sumoylation-defective mutant Ubc9 is able to function as a co-activator of the chicken ovalbumin upstream promoter-transcription factor I, suggesting that the co-activator ability is distinct from the sumoylation activity. Of interest, chromatin immunoprecipitation assays revealed that ectopically expressed chicken ovalbumin upstream promoter-transcription factor I and Ubc9 were recruited to the endogenous CYP11B2 promoter (Kurihara et al., 2005) . Other examples of Ubc9-regulated genes include estrogen receptor a (Kobayashi et al., 2004; Sentis et al., 2005) and the gene coding for the immediate-early 2 protein of human herpesvirus 6 (Tomoiu et al., 2006) .
Ubc9 is a single copy gene and is ubiquitously expressed in all human organs and tissues. However, Ubc9 is frequently upregulated in tumor specimens. For example, Ubc9 mRNA is overexpressed in lung adenocarcinoma, as detected by microarray analysis (McDoniels-Silvers et al., 2002) . By semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis and immunohistochemistry, we detected overexpression of Ubc9 in ovarian carcinoma compared with the matched normal ovarian epithelial cells as well as other types of tumors . Moreover, Ubc9 is the most highly expressed protein in protein extracts from melanoma infiltrated lymph nodes (Moschos et al., 2007) . In support of this, we have earlier shown that Ubc9 is able to induce Bcl-2 expression in the breast cancer cell line MCF-7 (Lu et al., 2006) , which could explain in part why ectopic expression of Ubc9 enhances tumor growth, whereas suppression of Ubc9 function reduces tumor growth in MCF-7 model . However, little is known whether Ubc9 can promote cell invasion and tumor metastasis.
In this study, we present evidence that Ubc9 promotes invasion and metastasis in a sumoylation-independent manner. More importantly, we show that several microRNAs (miRNAs) are regulated by Ubc9. In particular, miR-224 is negatively regulated by Ubc9. We suggest that Ubc9 promotes invasion and metastasis in part through downregulation of a putative tumor suppressor miR-224.
Results

Effect of Ubc9 on cell invasion and metastasis
We have earlier shown that ectopic expression of Ubc9 enhances, whereas suppression of Ubc9 function decreases breast tumor growth in the xenograft animal model using MCF-7 cells , suggesting that Ubc9 has a causal function in breast tumorigenesis. However, it is not clear whether Ubc9 affects breast tumor cell invasion and metastasis. Therefore, we generated stable clones from the metastatic breast cancer MDA-MB-231 cells expressing Ubc9-WT or Ubc9-DN. After verification of the exogenous gene expression, over 10 stable MDA-MB-231 transfectants for Ubc9-WT or Ubc9-DN or vector control were pooled. Supplementary Figure 1A showed that the exogenous Ubc9-WT or Ubc9-DN level was highly expressed compared with the endogenous counterpart. To confirm that the ectopically expressed Ubc9-WT or Ubc9-DN affects protein sumoylation, western blot was carried out using anti-SUMO antibody. As expected, Ubc9-DN suppressed, whereas Ubc9-WT enhanced protein sumoylation (Supplementary Figure 1B) . Next, we examined the effect of Ubc9-WT or Ubc9-DN on cell invasion. Matrigel chamber assay revealed that Ubc9-WT increased cell invasion with about as twice invasive cells as the vector control (Figures 1a and b) . This result is consistent with the report that Ubc9 has a function in prostate cancer cell invasion (Kim et al., 2006) . However, to our surprise, Ubc9-DN also increased cell invasion by over twofold compared with the vector control ( Figures  1a and b) , just as Ubc9-WT. We then tested another two metastatic breast cancer cell lines LM2-4142 (Minn et al., 2005) and MDA-MB-468 with ectopic expression of Ubc9-DN or Ubc9-WT and obtained similar results to those of MDA-MB-231 cells (Supplementary Figure 2) . Therefore, these results suggest that Ubc9 promotes breast cancer cell invasion independent of sumoylation.
To further investigate the function of Ubc9 in cell invasion, we suppressed Ubc9 expression by Ubc9 specific siRNAs. As shown in Figure 1c , both Ubc9-siRNA-1 and Ubc9-siRNA-2 efficiently suppressed Ubc9 expression, as detected by western blot. Invasion assay indicated that Ubc9-siRNA-1 substantially inhibited invasiveness of MDA-MB-231 cells (Figures 1c and  d) . A similar inhibitory result was also seen with Ubc9-siRNA-2, which was derived from a different location of the Ubc9 sequence.
To determine whether Ubc9-mediated invasion is due to increased cell proliferation, we measured cell growth by MTT. As shown in Supplementary Figures 3A and B , in both MDA-MB-231 and LM2-4142 cells, Ubc9 had no significant effect on cell growth, suggesting that the observed invasion enhanced by Ubc9 is not likely because of cell proliferation differences. However, Ubc9-siRNA inhibited cell growth (Supplementary Figure 3C) , which is presumably because the degree of knockdown was severe. It is known that Ubc9 is an essential gene and knockout of Ubc9 causes embryo lethality (Nacerddine et al., 2005) .
Effect of Ubc9 on metastasis in an experimental model To determine whether Ubc9 has a function in tumor metastasis, we performed experimental metastasis assays by injecting the transfected MDA-MB-231 cells into female nude mice through tail veins. Similar to invasion results, both Ubc9-DN and Ubc9-WT caused more metastases than the vector control. For example, average lung tumor nodules were between 80 and 100 for Ubc9-DN and Ubc9-WT, whereas there were about 20 for the vector control (Figures 2a and b) . In contrast, suppression of Ubc9 by Ubc9-siRNA-1 caused a substantial reduction of tumor nodules (Figures 2c and  d) . These results further suggest that Ubc9 promotes tumor invasion and metastasis independent of its SUMO-conjugation activity.
miR-224 is negatively regulated by Ubc9
Given the importance of Ubc9 in tumor invasion and metastasis, next we determined the molecular link between Ubc9 and tumor invasion, and set to profile gene expression for MDA-MB-231 cells expressing Ubc9-WT or vector alone. As Ubc9-DN had the same effect on invasion and metastasis as Ubc9-WT, it was not included in the profiling assays. We were particularly interested in miRNAs because as non-coding RNAs, miRNAs have been shown to have an important function in tumor metastasis (Ma et al., 2007) . We profiled a total of 474 miRNAs by real-time PCR. As shown in Figure 3a , the majority of miRNAs were expressed at similar levels between Ubc9-WT and vector control (also see Supplementary Table 1) . Only a small fraction of miRNAs were differentially expressed. We selected 35 miRNAs of them, which revealed the most differential expression (Supplementary Table 1 , highlighted in red) for further verification, and showed that three miRNAs, miR-224, miR-200b and miR-559, were most downregulated or upregulated (Figure 3b) . Initial characterization suggested a function of miR-224 in cell invasion and the computer-aided algorithms indicated that several metastasis-related genes are potential targets for miR-224. Furthermore, suppression of miR-200b and miR-559 by antagomirs revealed only a slight inhibition of invasion. Therefore, we chose miR-224 in this study. We further confirmed that both Ubc9-WT and Ubc9-DN suppressed miR-224 by TaqMan real-time PCR (Figure 3c ).
In contrast, Ubc9-siRNAs increased its expression (Figure 3d ). Figure 4B) .
To determine whether miR-224 is an important effector in the Ubc9-mediated cell invasion, we introduced the miR-224 expression vector into the Ubc9-overexpressing MDA-MB-231 cells by infection and then tested whether miR-224 can block Ubc9-induced invasion. As shown in Figure 4c , miR-224 significantly suppressed Ubc9-induced invasion. Compared with the pCDH vector control, miR-224 caused over 50% reduction of invasion in the cells, which were earlier transfected with the pCMV vector control. In the cells, which were earlier transfected with Ubc9-WT, we also found a similar reduction of invasion when miR-224 was compared with the pCDH vector control (Figure 4c ). Consistent with our earlier findings (Figure 2a ), the number of overall invaded cells for the Ubc9-WT cells (both pCDH and miR-224) was higher than for the pCMV vector controls (both pCDH and miR-224). Therefore, the Ubc9-mediated cell invasion can be partially reversed by ectopic expression of miR-224.
miR-224 directly targets CDC42 and CXCR4
To determine how miR-224 impacts cell invasion, we tested several predicted target genes based on computeraided analysis, which included several commonly cited miRNA target prediction programs TargetScan4 (13), miRBase Target5 (http://microrna.sanger.ac.uk/cgi-bin/ targets/v5/search.pl), PicTar (14) and miRanda (17). This search combined with luciferase reporter assays identified CDC42 and CXCR4 as targets for miR-224; on the other hand, miR-224 had no effect on another two putative targets ATF2 and Jag1, although miR-224 was predicted to interact with the 3 0 -untranslated region (UTR) of these two genes. As shown in Figure 5b , miR-224 suppressed the luciferase activity of Luc-CDC42-UTR by 60% compared with vector control. To determine the importance of the putative miR-224-binding site in CDC42-UTR (Figure 5a, To further determine the effect of miR-224, we suppressed the endogenous miR-224 by anti-miR-224 and this suppression was able to enhance the luciferase activity by about 30% (Figure 5b, right) . Finally, western blot detected a reduced level of the endogenous CDC42 by miR-224 compared with vector control, further supporting a suppressive function of miR-224 in CDC42 (Figure 5c ). Similar to the results of CDC42, we showed that miR-224 also suppressed CXCR4 (Figure 5e ). Further analysis indicated that miR-224 exerted its silencing function by directly binding to the miR-224 site in the 3 0 -UTR of CXCR4 (Figure 5e ). In contrast, anti-miR-224 enhanced the luciferase activity of Luc-CXCR4-UTR (Figure 5e, right) . Finally, miR-224 suppressed the endogenous CXCR4 (Figure 5f ).
Suppression of CDC42 and CXCR4 inhibits Ubc9-mediated cell invasion
To address whether Ubc9 indirectly affects CDC42 and CXCR4 levels, we examined CDC42 and CXCR4 levels in Ubc9-DN or Ubc9-WT cells. As expected, Ubc9-DN and Ubc9-WT upregulated CDC42 and CXCR4 ( Figure 6a ). Next, we suppressed CDC42 and CXCR4 by RNAi (Figure 6b ). We noted that knockdown of CDC42 also slightly suppressed CXCR4, and vice versa for some reason. We then determined the effect of knockdown of these two genes on cell invasion. As shown in Figure 6c , the number of invaded cells for CDC42-sh#2 or CXCR4-sh#4 was substantially lower than that for vector control even under different backgrounds (vector, Ubc9-DN or Ubc9-WT). Moreover, double knockdown (CDC42-sh#2 þ CXCR4-sh#4) caused further suppression of invasion. Separate knockdown experiments with shRNA (or siRNA) derived from different parts of these two genes also suppressed cell invasion (Supplementary Figure 5) . Together, these results are consistent with earlier findings that CDC42 and CXCR4 have a function in cell migration and tumor metastasis, and specific suppression of CDC42 and CXCR4 by RNAi inhibited cell mobility or cell migration, which may provide a molecular explanation as to why Ubc9 is able to promote cell invasion and metastasis. 
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Discussion
Ubc9 is well known for its key function in protein sumoylation and sumoylation-mediated cellular pathways, ultimately impacting tumor initiation and progression (Mo and Moschos, 2005) . However, there is scarce information available in the literature as to whether and how Ubc9 impacts cell invasion and metastasis. In one report, ectopic expression Ubc9 was shown to be able to enhance invasion in prostate cancer cells through regulation of sumoylation of reptin because sumoylation is required for its repressive function, and disruption of sumoylation causes repression of the metastatic suppressor KAI1 (Kim et al., 2006) . Our study provides evidence, for the first time to our knowledge, that Ubc9 can promote invasion and metastasis in a sumoylation-independent manner. As a multi-functional protein, Ubc9 has been shown to mediate diverse cellular pathways. Unlike other E2-conjugating enzymes involved in ubiquitination, Ubc9 is the only E2 enzyme essential for sumoylation and thus, it has a crucial function in determining sumoylation status of many SUMO substrates. Therefore, its expression or activity is believed to be essential for these SUMO pathways. In contrast to the well-known sumoylation-associated function of Ubc9, much less is known about its sumoylation-independent function. Emerging evidence suggests that Ubc9 can function as either a modulator of enzymatic activity or a transcriptional co-factor. In addition to the earlier mentioned proteins such as Vsx-1 (Kurtzman and Schechter, 2001 ), glucocorticoid receptors (Kaul et al., 2002) and estrogen receptor a (Kobayashi et al., 2004; Sentis et al., 2005) , a recent report indicates that overexpression of either Ubc9-WT or Ubc9-DN inhibits GLUT4 degradation and promotes its targeting to the unique insulinresponsive GLUT4 storage compartment (Liu et al., 2007) . Thus, Ubc9 is implicated in the insulin-responsive glucose transport by a mechanism independent of its catalytic activity (Liu et al., 2007) . With regard to the function of Ubc9 as a transcriptional co-factor, Ubc9 was shown to be able to enhance pleomorphic adenoma gene like-2 (PLAGL2), a transactivator of the surfactant protein-C, by a similar sumoylation-independent mechanism (Guo et al., 2008) . Moreover, chromatin immunoprecipitation assay identifies the association of PLAGL2 and Ubc9 with the surfactant protein-C promoter in vivo, showing the function of Ubc9 as a co-factor of PLAGL2 to mediate PLAGL2 interactive surfactant protein-C promoter activity (Guo et al., 2008) . This finding is consistent with the report that both wild type and mutant Ubc9 can interact with chicken ovalbumin upstream promoter-transcription factor I to activate the CYP11B2 promoter (Kurihara et al., 2005) . In agreement with these reports, our study further suggests that Ubc9-mediated invasion could be 
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separated from its ability to conjugate SUMO to the substrates because sumoylation-deficient Ubc9 (Ubc9-DN) is able to promote cell invasion and metastasis. More importantly, both Ubc9-DN and Ubc9-WT have the same negative effect on miR-224 expression.
The mechanism underlying the Ubc9-mediated invasion and metastasis may be complex. Our study suggests that at least miRNAs such as miR-224 could be one of its downstream players. MiRNAs are small RNA molecules that are capable of regulating coding genes at the posttranscriptional level (Bartel, 2004; Pillai, 2005; Zamore and Haley, 2005) . Increasing evidence indicates that miRNAs are the key players that affect not only tumor growth, but also tumor invasion and metastasis (Calin and Croce, 2006; Ma and Weinberg, 2008) . For example, miR-10b serves as a breast cancer metastasis initiation factor because ectopic expression of miR-10b affects invasion and metastasis, but not tumor growth (Ma et al., 2007) . On the other hand, miR-200 is a metastatic suppressor by directly targeting the mRNA of the E-cadherin transcriptional repressors ZEB1 and ZEB2, leading to upregulation of E-cadherin (Korpal et al., 2008; Park et al., 2008) . These findings prompt us to profile miRNA expression in the MDA-MB-231 cells overexpressing Ubc9. Our study shows that miR-224 is specifically suppressed by Ubc9. Therefore, our study establishes a novel function of Ubc9 as a regulator of miRNA expression. However, it is not clear how Ubc9 regulates miRNA expression. Available evidence suggests that regulation of miRNAs can take place at the transcriptional or posttranscriptional level. At the transcriptional level, several miRNAs, such as miR-17B92, miR-34, miR-21 and miR-223, have been shown to be regulated by transcription factors, such as c-MYC (He et al., 2005) , p53 (He et al., 2007) , Stat3 (Loffler et al., 2007) , REST (Singh et al., 2008) , NFI-A and C/EBPa (Fazi et al., 2005) . On the other hand, the posttranscriptional regulation could take place at the miRNA processing or miRNA stability. For instance, Lin28, a developmentally regulated RNA-binding protein, was shown to selectively block the processing of pri-let-7 miRNAs in embryonic cells (Viswanathan et al., 2008) .
On the basis of our preliminary results indicating that levels of both pre-miR-224 and pri-miR-224 are also downregulated by Ubc9 (Zhu et al, unpublished) , we believe that Ubc9-mediated repression of miR-224 is more likely to occur at the transcriptional level. As miR-224 is an intronic gene embedded in the GABRE Ubc9-mediated invasion and metastasis S Zhu et al gene (Wilke et al., 1997) , there are at least two possibilities that miR-224 can be transcriptionally regulated. One possibility is that miR-224 is co-regulated by the GAGRE gene. Alternatively, miR-224 may carry its own promoter. These possibilities are currently under investigation. Dissection of Ubc9-mediated miRNA expression will provide a better understanding of how Ubc9 impacts cell invasion and metastasis. In summary, we show that Ubc9 is a multi-functional protein that promotes cell invasion and metastasis independent of sumoylation. Moreover, Ubc9 negatively regulates miR-224. Finally, identification of CDC42 and CXCR4 as direct targets for miR-224 provides new insight into Ubc9-mediated cell invasion and metastasis. Therefore, given its important function in these aspects, Ubc9 may prove to be a potential therapeutic target for cancer intervention because Ubc9 is often upregulated in various types of tumors (McDoniels-Silvers et al., 2002; Moschos et al., 2007; Wu et al., 2009 ).
Materials and methods
Reagents
Primary antibody against Ubc9 was custom made; other primary antibodies were from the following vendors: CDC42 from Cell Signal, CXCR from Applied Biological Materials (British Columbia, Canada), SUMO-1 from Invitrogen (Carlsbad, CA, USA). Secondary antibodies conjugated with IRDye 800CW or IRDye 680 were purchased from LI-COR Biosciences (Lincoln, NE, USA). PCR primers were purchased from Sigma-Genosys (Woodland, TX, USA) or IDT (Coralville, IA, USA) and locked nucleic acid (LNA) antagomirs were purchased from IDT. CDC42 shRNAs and CXCR4 shRNAs were purchased from Open Biosystems (Huntsville, AL, USA). Synthetic CDC42 siRNA was from Santa Cruz (Santa Cruz, CA, USA). Ubc9-siRNAs were from Applied Biosystems (Foster City, CA, USA).
Cell culture
All cell lines were purchased from ATCC (Manassas, VA, USA) except LM2-4142 (Minn et al., 2005) , a generous gift from Dr Joan Massague´. MDA-MB-231, LM2-4142 and MDA-MB-468 cells were grown in RPMI 1640 (Cambrex, Walkersville, MD, USA) supplemented with 10% fetal bovine serum (Sigma-Aldrich, St Louis, MO, USA). 293T cells were cultured in Dulbecco's modified Eagle's medium (Cambrex) supplemented with 10% fetal bovine serum. All media contained 2 mM glutamine, 100 units of penicillin/ml and 100 mg of streptomycin/ml. Cells were incubated at 37 1C and supplemented with 5% CO 2 in the humidified chamber. miRNA profiling Total RNA was extracted from MDA-MB-231 cells stably overexpressing Ubc9-WT and then was subject to miRNA profiling using QuantiMir kit (System Biosciences, Mountain View, CA, USA). A total of 474 miRNAs registered in Sanger miRBases (version 9.2) were profiled in this study; 3 mg total RNA was first anchor-tailed by poly A polymerase, and then annealed by an oligo dT adapter at 60 1C for 5 min. For RT, 10 ml of RT master mix (1.5 ml of water, 4 ml 5 Â buffer, 1.5 ml of 0.1 M DTT, 2 ml of 10 mM dNTPs, 1 ml of reverse transcriptase) were combined with 10 ml template (poly A tailed). The 20 ml RT reaction was incubated at 42 1C for 60 min, 95 1C for 10 min, cooled to room temperature and then diluted sixfold with 100 ml of water. After RT, real-time PCR was performed in a 96-well optical PCR plate using 7500 HT PCR instrument (Applied Biosystems). The reaction solution contained 10 ml of 2 Â SYBR green PCR master mix (Applied Biosystems), 5.5 ml of water, 0.5 ml of 5 mM universal primer, 2 ml of 5 mM forward primer (the mature miRNA sequence converted to DNA) and 2 ml of the diluted cDNA. Dissociation curves were typically generated post-run for analysis of amplicon species. U6 was used as an internal control.
Plasmids
Wild-type Ubc9 (Ubc9-WT) or dominant negative mutant Ubc9 (Ubc9-DN) was constructed in pCMV-Myc as described earlier (Lu et al., 2006) . The same DNA fragment carrying Myc-Ubc9 or Myc-Ubc9-DN was also cloned into a lentiviral vector pCDH-CMV-MCS-EF1-copGFP (pCDH, System Biosciences). Restriction enzymes sites were introduced by PCR using standard methods.
To construct a plasmid expressing miR-224, we first amplified B0.5 kb DNA fragment covering the pre-miRNA, using genomic DNA from a healthy blood donor as a template. PCR reactions were performed using the high fidelity Phusion enzyme (New England Biolabs Ipswich, MA, USA) and corresponding specific primers: miR-224-5.1 (sense) 5 0 -AG TCAGTCTCTGGATGAGGG; miR-224-Not1-3.1 (antisense) 5 0 -GCGGCCGCGTAAGTATGCTCCAGATGG in which Not1 site was underlined. The amplified fragment was first cloned into a PCR cloning vector (PCR8, Invitrogen) and subsequently cloned into the lentiviral vector pCDH at EcoR1 and Not1 sites in which the EcoR1 site was from the PCR cloning vector. Expression of the mature miR-224 was verified by TaqMan real-time PCR. The luciferase-UTR reporter plasmids, such as Luc-CDC42-UTR and Luc-CXCR4-UTR, were constructed by introducing the CDC42 or CXCR4 3 0 -UTR carrying a putative miR-224-binding site into pGL3 control vector (Promega, Madison, WI, USA). We amplified the CDC42 or CXCR4 3 0 -UTR sequence from MCF-10A cDNA using PCR primers: CDC42-UTR-5.1 (sense) 5 0 -AATTCATTAACCAGTGGTTAGC; CDC42-UTRNot1-3.1 (antisense) 5 0 -GCGGCCGCACAGATGTCTGTCTT CTAGCAC; CXCR4-UTR-5.1 (sense) 5 0 -CACAGATGTAAA AGACTTTTTTT; CXCR4-UTR-Not1-3.1 (antisense) 5 0 -GCG GCCGCTTTAACATGTACTTTTATTAAC; The PCR products were also first cloned into a PCR cloning vector and then subcloned into a modified pGL3 control vector as described earlier (Sachdeva et al., 2009) . To delete the putative miR-224-binding site in the 3 0 -UTR of CDC42 or CXCR4, we used the two-step PCR method in which two sets of overlapped primers were used to amplify two fragments followed by a second PCR as described earlier (Zhu et al., 2008) . All the amplified products were verified by DNA sequencing before cloning into the final destination vector.
Transfection
Transfection of Ubc9-siRNAs and anti-miR-224 LNA oligo was performed using RNAifectin reagent (Applied Biological Materials) following the manufacturer's protocol. In brief, cells (1 Â 10 5 ) were seeded in six-well plates and incubated overnight. About 100 pmol Ubc9-siRNAs or anti-miR-224 per well was used for transfection.
Transfection of 293T cells was carried out using the calcium phosphate method, as described earlier (Mo and Beck, 1999) . The transfected cells were cultured overnight before they were Ubc9-mediated invasion and metastasis S Zhu et al harvested and lysed for luciferase assay or for extraction of protein or RNA.
Stable clones
Stable Ubc9-WT or Ubc9-DN expressing clones were established by transfection, followed by selection in the presence of puromycin (1 mg/ml). Individual colonies (over 10) were pooled after verification of the exogenous gene expression by western blot.
Luciferase assay
Luciferase assay was carried out in 293T cells to determine the effect of miR-224 on the activity of Luc-CDC42-UTR or Luc-CXCR4-UTR. First, cells were transfected with appropriate plasmids in 12-well plates. Then, the cells were harvested and lysed for luciferase assay 24 h after transfection. The assays were carried out using a luciferase assay kit (Promega) according to the manufacturer's protocol. b-galactosidase or renilla luciferase was used for normalization.
PCR/RT-PCR and real-time RT-PCR
PCR reactions were performed to amplify the 3 0 -UTR of CDC42 or CXCR4 according to the standard three-step procedure. Annealing temperature varied depending on the primers used. For RT-PCR, we isolated the total RNA using Trizol reagent (Invitrogen) as per the manufacturer's protocol. To detect mature miR-224 expression in cell lines, we also used Trizol reagent to isolate total RNA, which was then amplified by TaqMan stem-loop RT-PCR method, as described earlier (Chen et al., 2005; Lao et al., 2006) .
Western blot
Cells were harvested and protein was extracted 2 days after transfection as described earlier (Si et al., 2007) .
Invasion assays
Effect of Ubc9 or miR-224 on the invasion ability of MDA-MB-231, LM2-4142 or MDA-MB-468 cells was determined using matrigel invasion chambers (BD Biosciences). Cells infected with Ubc9-WT, Ubc9-DN and miR-224 or cells transfected with Ubc9-siRNAs were seeded into inserts at 2-4 Â 10 4 per insert in serum-free medium and then transferred to wells filled with the culture medium containing 10% fetal bovine serum. After 24 h incubation, non-invading cells on the top of the membrane were removed by cotton swabs. Invaded cells on the bottom of the membrane were fixed, followed by staining with 0.05% crystal violet. Invaded cells on the membrane were then counted as follows. As the distribution of cells on the membrane was not always even, we first took a picture at a low magnificence and then enlarged the image in a computer screen with grids so that all of the cells on the entire membrane were counted.
Experimental metastasis assay
Female athymic nude (nu/nu) mice (4-5 weeks old) were purchased from Harlan Sprague Dawley (Indianapolis, IN, USA) and were maintained in the Southern Illinois University School of Medicine's accredited animal facility. All animal studies were conducted in accordance with NIH animal use guidelines and a protocol approved by SIU Animal Care Committee. In brief, 1.5 Â 10 6 exponentially growing MDA-MB-231 cells (vector control, Ubc9-WT, Ubc9-DN, scrambled oligo or Ubc9-siRNA-1) were injected into nude mice through tail veins. Four weeks after injection, the animals were killed. The lungs were harvested, fixed in Bouin's solution and tumor nodules were countered.
Statistical analysis
Statistical analysis of data was performed using the Student's t-test. Differences with P-values o0.05 are considered significant.
Abbreviations miRNA, microRNA; PCR, polymerase chain reaction; RT, reverse transcription; SUMO, small ubiquitin-like modifier; UTR, untranslated region.
